APO Research
Talk to an analyst

APO RESEARCH · REPORT

Granulocyte-Colony Stimulating Factor (G-CSF)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Granulocyte-Colony Stimulating Factor (G-CSF) Industry Growth and Trends Forecast to 2032

20 December 2025126 pages

Choose your research edition.

Industry ResearchGranulocyte-Colony Stimulating Factor (G-CSF) Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Granulocyte-Colony Stimulating Factor (G-CSF) Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Granulocyte-Colony Stimulating Factor (G-CSF) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Granulocyte-Colony Stimulating Factor (G-CSF) Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Granulocyte-Colony Stimulating Factor (G-CSF) Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Granulocyte-Colony Stimulating Factor (G-CSF) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Granulocyte-Colony Stimulating Factor (G-CSF) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Granulocyte-Colony Stimulating Factor (G-CSF) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Granulocyte-Colony Stimulating Factor (G-CSF) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Granulocyte-Colony Stimulating Factor (G-CSF) include Changchun GeneScience Pharmaceutical, Evive Biotech, Teva, CSPC Baike Biopharma, Shanghai Sunway Biotech, Sandoz, Amoytop Biotech, Qilu Pharmaceutical and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Granulocyte-Colony Stimulating Factor (G-CSF) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Granulocyte-Colony Stimulating Factor (G-CSF) market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Granulocyte-Colony Stimulating Factor (G-CSF) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Granulocyte-Colony Stimulating Factor (G-CSF).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Granulocyte-Colony Stimulating Factor (G-CSF) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Granulocyte-Colony Stimulating Factor (G-CSF) Market by Company

Changchun GeneScience Pharmaceutical

Evive Biotech

Teva

CSPC Baike Biopharma

Shanghai Sunway Biotech

Sandoz

Amoytop Biotech

Qilu Pharmaceutical

Mylan

Lunan Pharmaceutical

Kexing Biopharm

Jiangsu Hengrui Pharmaceuticals

Pfizer

North China Pharmaceutical

Hangzhou Jiuyuan Gene Engineering

Harbin Pharmaceutical Group

SL Pharm

Amgen

Tanvex BioPharma

Kashiv BioSciences

Italfarmaco SpA

Coherus BioSciences

Chugai Pharmaceutical

Granulocyte-Colony Stimulating Factor (G-CSF) Segment by Type

Long-acting G-CSF

Short-acting G-CSF

Granulocyte-Colony Stimulating Factor (G-CSF) Segment by Application

Neutropenia

Other

Granulocyte-Colony Stimulating Factor (G-CSF) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granulocyte-Colony Stimulating Factor (G-CSF) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Granulocyte-Colony Stimulating Factor (G-CSF) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granulocyte-Colony Stimulating Factor (G-CSF).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Granulocyte-Colony Stimulating Factor (G-CSF) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Granulocyte-Colony Stimulating Factor (G-CSF) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Long-acting G-CSF Table 2. Major Company of Short-acting G-CSF Table 3. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (k units) Table 5. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Type (2021-2026) Table 8. Global Granulocyte-Colony Stimulating Factor (G-CSF) Price by Type (2021-2026) & (US$/unit) Table 9. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2027-2032) & (k units) Table 10. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Type (2027-2032) Table 13. Global Granulocyte-Colony Stimulating Factor (G-CSF) Price by Type (2027-2032) & (US$/unit) Table 14. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (k units) Table 15. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (k units) Table 17. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (k units) Table 21. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (US$ Million) Table 24. Granulocyte-Colony Stimulating Factor (G-CSF) Industry Trends Table 25. Granulocyte-Colony Stimulating Factor (G-CSF) Industry Drivers Table 26. Granulocyte-Colony Stimulating Factor (G-CSF) Industry Opportunities and Challenges Table 27. Granulocyte-Colony Stimulating Factor (G-CSF) Industry Restraints Table 28. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Company (2021-2026) Table 30. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Company (2021-2026) & (k units) Table 31. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Share by Company (2021-2026) Table 32. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Granulocyte-Colony Stimulating Factor (G-CSF) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Granulocyte-Colony Stimulating Factor (G-CSF) Major Company Production Sites and Headquarters Table 35. Global Granulocyte-Colony Stimulating Factor (G-CSF) Company, Product Type & Application Table 36. Global Granulocyte-Colony Stimulating Factor (G-CSF) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Granulocyte-Colony Stimulating Factor (G-CSF) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region (2021-2026) & (k units) Table 41. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Region (2021-2026) Table 44. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region (2027-2032) & (k units) Table 46. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Region (2027-2032) Table 49. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (k units) Table 52. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Application (2021-2026) Table 55. Global Granulocyte-Colony Stimulating Factor (G-CSF) Price by Application (2021-2026) & (US$/unit) Table 56. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2027-2032) & (k units) Table 57. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Application (2027-2032) Table 60. Global Granulocyte-Colony Stimulating Factor (G-CSF) Price by Application (2027-2032) & (US$/unit) Table 61. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (k units) Table 62. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (k units) Table 64. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (k units) Table 68. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (US$ Million) Table 71. Changchun GeneScience Pharmaceutical Company Information Table 72. Changchun GeneScience Pharmaceutical Business Overview Table 73. Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 75. Changchun GeneScience Pharmaceutical Recent Development Table 76. Evive Biotech Company Information Table 77. Evive Biotech Business Overview Table 78. Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 80. Evive Biotech Recent Development Table 81. Teva Company Information Table 82. Teva Business Overview Table 83. Teva Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Teva Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 85. Teva Recent Development Table 86. CSPC Baike Biopharma Company Information Table 87. CSPC Baike Biopharma Business Overview Table 88. CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 90. CSPC Baike Biopharma Recent Development Table 91. Shanghai Sunway Biotech Company Information Table 92. Shanghai Sunway Biotech Business Overview Table 93. Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 95. Shanghai Sunway Biotech Recent Development Table 96. Sandoz Company Information Table 97. Sandoz Business Overview Table 98. Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 100. Sandoz Recent Development Table 101. Amoytop Biotech Company Information Table 102. Amoytop Biotech Business Overview Table 103. Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 105. Amoytop Biotech Recent Development Table 106. Qilu Pharmaceutical Company Information Table 107. Qilu Pharmaceutical Business Overview Table 108. Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 110. Qilu Pharmaceutical Recent Development Table 111. Mylan Company Information Table 112. Mylan Business Overview Table 113. Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 115. Mylan Recent Development Table 116. Lunan Pharmaceutical Company Information Table 117. Lunan Pharmaceutical Business Overview Table 118. Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 120. Lunan Pharmaceutical Recent Development Table 121. Kexing Biopharm Company Information Table 122. Kexing Biopharm Business Overview Table 123. Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 125. Kexing Biopharm Recent Development Table 126. Jiangsu Hengrui Pharmaceuticals Company Information Table 127. Jiangsu Hengrui Pharmaceuticals Business Overview Table 128. Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 130. Jiangsu Hengrui Pharmaceuticals Recent Development Table 131. Pfizer Company Information Table 132. Pfizer Business Overview Table 133. Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 135. Pfizer Recent Development Table 136. North China Pharmaceutical Company Information Table 137. North China Pharmaceutical Business Overview Table 138. North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 140. North China Pharmaceutical Recent Development Table 141. Hangzhou Jiuyuan Gene Engineering Company Information Table 142. Hangzhou Jiuyuan Gene Engineering Business Overview Table 143. Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 145. Hangzhou Jiuyuan Gene Engineering Recent Development Table 146. Harbin Pharmaceutical Group Company Information Table 147. Harbin Pharmaceutical Group Business Overview Table 148. Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 150. Harbin Pharmaceutical Group Recent Development Table 151. SL Pharm Company Information Table 152. SL Pharm Business Overview Table 153. SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 155. SL Pharm Recent Development Table 156. Amgen Company Information Table 157. Amgen Business Overview Table 158. Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 159. Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 160. Amgen Recent Development Table 161. Tanvex BioPharma Company Information Table 162. Tanvex BioPharma Business Overview Table 163. Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 164. Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 165. Tanvex BioPharma Recent Development Table 166. Kashiv BioSciences Company Information Table 167. Kashiv BioSciences Business Overview Table 168. Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 169. Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 170. Kashiv BioSciences Recent Development Table 171. Italfarmaco SpA Company Information Table 172. Italfarmaco SpA Business Overview Table 173. Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 174. Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 175. Italfarmaco SpA Recent Development Table 176. Coherus BioSciences Company Information Table 177. Coherus BioSciences Business Overview Table 178. Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 179. Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 180. Coherus BioSciences Recent Development Table 181. Chugai Pharmaceutical Company Information Table 182. Chugai Pharmaceutical Business Overview Table 183. Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 184. Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio Table 185. Chugai Pharmaceutical Recent Development Table 186. North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 187. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (k units) Table 188. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country (2021-2026) Table 189. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032) & (k units) Table 190. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share Forecast by Country (2027-2032) Table 191. North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country (2021-2026) & (US$ Million) Table 193. North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Share by Country (2021-2026) Table 194. North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Share Forecast by Country (2027-2032) Table 196. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 197. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (k units) Table 198. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country (2021-2026) Table 199. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032) & (k units) Table 200. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share Forecast by Country (2027-2032) Table 201. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country (2021-2026) & (US$ Million) Table 203. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Share by Country (2021-2026) Table 204. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Share Forecast by Country (2027-2032) Table 206. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 207. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (k units) Table 208. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country (2021-2026) Table 209. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032) & (k units) Table 210. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share Forecast by Country (2027-2032) Table 211. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country (2021-2026) & (US$ Million) Table 213. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Market Share by Country (2021-2026) Table 214. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Market Share Forecast by Country (2027-2032) Table 216. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 217. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (k units) Table 218. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country (2021-2026) Table 219. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032) & (k units) Table 220. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share Forecast by Country (2027-2032) Table 221. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 222. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country (2021-2026) & (US$ Million) Table 223. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Market Share by Country (2021-2026) Table 224. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 225. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Market Share Forecast by Country (2027-2032) Table 226. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 227. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (k units) Table 228. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country (2021-2026) Table 229. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032) & (k units) Table 230. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share Forecast by Country (2027-2032) Table 231. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 232. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country (2021-2026) & (US$ Million) Table 233. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Market Share by Country (2021-2026) Table 234. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 235. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Market Share Forecast by Country (2027-2032) Table 236. Key Raw Materials Table 237. Raw Materials Key Suppliers Table 238. Granulocyte-Colony Stimulating Factor (G-CSF) Distributors List Table 239. Granulocyte-Colony Stimulating Factor (G-CSF) Customers List Table 240. Research Programs/Design for This Report Table 241. Authors List of This Report Table 242. Secondary Sources Table 243. Primary Sources List of Figures Figure 1. Granulocyte-Colony Stimulating Factor (G-CSF) Image Figure 2. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size (2021-2032) & (US$ Million) Figure 4. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales (2021-2032) & (k units) Figure 5. Long-acting G-CSF Image Figure 6. Global Long-acting G-CSF Sales YoY Growth (2021-2032) & (k units) Figure 7. Short-acting G-CSF Image Figure 8. Global Short-acting G-CSF Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Share by Type 2025 VS 2032 Figure 11. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Type in 2025 Figure 12. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Type in 2025 Figure 13. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Granulocyte-Colony Stimulating Factor (G-CSF) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Neutropenia Image Figure 24. Global Neutropenia Sales YoY Growth (2021-2032) & (k units) Figure 25. Other Image Figure 26. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Share by Application 2025 VS 2032 Figure 29. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Application in 2025 Figure 30. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Application in 2025 Figure 31. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Application in 2025 Figure 32. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Application in 2025 Figure 35. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share in Value by Application in 2025 Figure 39. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Granulocyte-Colony Stimulating Factor (G-CSF) Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Granulocyte-Colony Stimulating Factor (G-CSF) Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Long-acting G-CSF
  • Short-acting G-CSF
Applications
  • Neutropenia
  • Other
Companies covered
  • Changchun GeneScience Pharmaceutical
  • Evive Biotech
  • Teva
  • CSPC Baike Biopharma
  • Shanghai Sunway Biotech
  • Sandoz
  • Amoytop Biotech
  • Qilu Pharmaceutical
  • Mylan
  • Lunan Pharmaceutical
  • Kexing Biopharm
  • Jiangsu Hengrui Pharmaceuticals
  • Pfizer
  • North China Pharmaceutical
  • Hangzhou Jiuyuan Gene Engineering
  • Harbin Pharmaceutical Group
  • SL Pharm
  • Amgen
  • Tanvex BioPharma
  • Kashiv BioSciences
  • Italfarmaco SpA
  • Coherus BioSciences
  • Chugai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Granulocyte-Colony Stimulating Factor (G-CSF) Market by Type
  6. 1.3.1 Long-acting G-CSF
  7. 1.3.2 Short-acting G-CSF
  8. 1.4 Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Type
  9. 1.4.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Granulocyte-Colony Stimulating Factor (G-CSF) Industry Trends
  2. 2.2 Granulocyte-Colony Stimulating Factor (G-CSF) Industry Drivers
  3. 2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Industry Opportunities and Challenges
  4. 2.4 Granulocyte-Colony Stimulating Factor (G-CSF) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Granulocyte-Colony Stimulating Factor (G-CSF) Revenue (2021-2026)
  2. 3.2 Global Top Players by Granulocyte-Colony Stimulating Factor (G-CSF) Sales (2021-2026)
  3. 3.3 Global Top Players by Granulocyte-Colony Stimulating Factor (G-CSF) Price (2021-2026)
  4. 3.4 Global Granulocyte-Colony Stimulating Factor (G-CSF) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Granulocyte-Colony Stimulating Factor (G-CSF) Major Company Production Sites & Headquarters
  6. 3.6 Global Granulocyte-Colony Stimulating Factor (G-CSF) Company, Product Type & Application
  7. 3.7 Global Granulocyte-Colony Stimulating Factor (G-CSF) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Granulocyte-Colony Stimulating Factor (G-CSF) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Granulocyte-Colony Stimulating Factor (G-CSF) Tier 1, Tier 2, and Tier 3
4 Granulocyte-Colony Stimulating Factor (G-CSF) Regional Status and Outlook
  1. 4.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Historic Market Size by Region
  3. 4.2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Forecasted Market Size by Region
  7. 4.3.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Granulocyte-Colony Stimulating Factor (G-CSF) by Application
  1. 5.1 Granulocyte-Colony Stimulating Factor (G-CSF) Market by Application
  2. 5.1.1 Neutropenia
  3. 5.1.2 Other
  4. 5.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Application
  5. 5.2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Changchun GeneScience Pharmaceutical
  2. 6.1.1 Changchun GeneScience Pharmaceutical Company Information
  3. 6.1.2 Changchun GeneScience Pharmaceutical Business Overview
  4. 6.1.3 Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  6. 6.1.5 Changchun GeneScience Pharmaceutical Recent Developments
  7. 6.2 Evive Biotech
  8. 6.2.1 Evive Biotech Company Information
  9. 6.2.2 Evive Biotech Business Overview
  10. 6.2.3 Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  12. 6.2.5 Evive Biotech Recent Developments
  13. 6.3 Teva
  14. 6.3.1 Teva Company Information
  15. 6.3.2 Teva Business Overview
  16. 6.3.3 Teva Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Teva Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  18. 6.3.5 Teva Recent Developments
  19. 6.4 CSPC Baike Biopharma
  20. 6.4.1 CSPC Baike Biopharma Company Information
  21. 6.4.2 CSPC Baike Biopharma Business Overview
  22. 6.4.3 CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  24. 6.4.5 CSPC Baike Biopharma Recent Developments
  25. 6.5 Shanghai Sunway Biotech
  26. 6.5.1 Shanghai Sunway Biotech Company Information
  27. 6.5.2 Shanghai Sunway Biotech Business Overview
  28. 6.5.3 Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  30. 6.5.5 Shanghai Sunway Biotech Recent Developments
  31. 6.6 Sandoz
  32. 6.6.1 Sandoz Company Information
  33. 6.6.2 Sandoz Business Overview
  34. 6.6.3 Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  36. 6.6.5 Sandoz Recent Developments
  37. 6.7 Amoytop Biotech
  38. 6.7.1 Amoytop Biotech Company Information
  39. 6.7.2 Amoytop Biotech Business Overview
  40. 6.7.3 Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  42. 6.7.5 Amoytop Biotech Recent Developments
  43. 6.8 Qilu Pharmaceutical
  44. 6.8.1 Qilu Pharmaceutical Company Information
  45. 6.8.2 Qilu Pharmaceutical Business Overview
  46. 6.8.3 Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  48. 6.8.5 Qilu Pharmaceutical Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Lunan Pharmaceutical
  56. 6.10.1 Lunan Pharmaceutical Company Information
  57. 6.10.2 Lunan Pharmaceutical Business Overview
  58. 6.10.3 Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  60. 6.10.5 Lunan Pharmaceutical Recent Developments
  61. 6.11 Kexing Biopharm
  62. 6.11.1 Kexing Biopharm Company Information
  63. 6.11.2 Kexing Biopharm Business Overview
  64. 6.11.3 Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  66. 6.11.5 Kexing Biopharm Recent Developments
  67. 6.12 Jiangsu Hengrui Pharmaceuticals
  68. 6.12.1 Jiangsu Hengrui Pharmaceuticals Company Information
  69. 6.12.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  70. 6.12.3 Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  72. 6.12.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  73. 6.13 Pfizer
  74. 6.13.1 Pfizer Company Information
  75. 6.13.2 Pfizer Business Overview
  76. 6.13.3 Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  78. 6.13.5 Pfizer Recent Developments
  79. 6.14 North China Pharmaceutical
  80. 6.14.1 North China Pharmaceutical Company Information
  81. 6.14.2 North China Pharmaceutical Business Overview
  82. 6.14.3 North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  84. 6.14.5 North China Pharmaceutical Recent Developments
  85. 6.15 Hangzhou Jiuyuan Gene Engineering
  86. 6.15.1 Hangzhou Jiuyuan Gene Engineering Company Information
  87. 6.15.2 Hangzhou Jiuyuan Gene Engineering Business Overview
  88. 6.15.3 Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  90. 6.15.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
  91. 6.16 Harbin Pharmaceutical Group
  92. 6.16.1 Harbin Pharmaceutical Group Company Information
  93. 6.16.2 Harbin Pharmaceutical Group Business Overview
  94. 6.16.3 Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  96. 6.16.5 Harbin Pharmaceutical Group Recent Developments
  97. 6.17 SL Pharm
  98. 6.17.1 SL Pharm Company Information
  99. 6.17.2 SL Pharm Business Overview
  100. 6.17.3 SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  102. 6.17.5 SL Pharm Recent Developments
  103. 6.18 Amgen
  104. 6.18.1 Amgen Company Information
  105. 6.18.2 Amgen Business Overview
  106. 6.18.3 Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  108. 6.18.5 Amgen Recent Developments
  109. 6.19 Tanvex BioPharma
  110. 6.19.1 Tanvex BioPharma Company Information
  111. 6.19.2 Tanvex BioPharma Business Overview
  112. 6.19.3 Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  114. 6.19.5 Tanvex BioPharma Recent Developments
  115. 6.20 Kashiv BioSciences
  116. 6.20.1 Kashiv BioSciences Company Information
  117. 6.20.2 Kashiv BioSciences Business Overview
  118. 6.20.3 Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  120. 6.20.5 Kashiv BioSciences Recent Developments
  121. 6.21 Italfarmaco SpA
  122. 6.21.1 Italfarmaco SpA Company Information
  123. 6.21.2 Italfarmaco SpA Business Overview
  124. 6.21.3 Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  126. 6.21.5 Italfarmaco SpA Recent Developments
  127. 6.22 Coherus BioSciences
  128. 6.22.1 Coherus BioSciences Company Information
  129. 6.22.2 Coherus BioSciences Business Overview
  130. 6.22.3 Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  132. 6.22.5 Coherus BioSciences Recent Developments
  133. 6.23 Chugai Pharmaceutical
  134. 6.23.1 Chugai Pharmaceutical Company Information
  135. 6.23.2 Chugai Pharmaceutical Business Overview
  136. 6.23.3 Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolio
  138. 6.23.5 Chugai Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country
  2. 7.1.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026)
  4. 7.1.3 North America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country
  6. 7.2.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country (2021-2026)
  8. 7.2.3 North America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country
  2. 8.1.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026)
  4. 8.1.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country
  6. 8.2.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country
  2. 9.1.1 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country
  6. 9.2.1 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country
  2. 10.1.1 South America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026)
  4. 10.1.3 South America Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country
  6. 10.2.1 South America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country (2021-2026)
  8. 10.2.3 South America Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country
  2. 11.1.1 Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country
  6. 11.2.1 Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Granulocyte-Colony Stimulating Factor (G-CSF) Value Chain Analysis
  2. 12.1.1 Granulocyte-Colony Stimulating Factor (G-CSF) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Granulocyte-Colony Stimulating Factor (G-CSF) Production Mode & Process
  7. 12.2 Granulocyte-Colony Stimulating Factor (G-CSF) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Granulocyte-Colony Stimulating Factor (G-CSF) Distributors
  10. 12.2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst